Histone lysine demethylase KDM5B maintains chronic myeloid leukemia via multiple epigenetic actions-Reference-Cited by-同舟云学术

Histone lysine demethylase KDM5B maintains chronic myeloid leukemia via multiple epigenetic actions

Published:2020-02 Issue: Volume:82 Page:53-65
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Xue Shen,Lam Yuk Man,He Zhikai,Zheng Yan,Li Lin,Zhang Yonghong,Li Chen,Mbadhi Magdaleena Naemi,Zheng Lanlan,Cheng Zhongshan,Liu Ying,Wang Xuanbing,Chan Li Chong,Ng Ray Kit,Zhang Jingxuan

Funder

Core

University of Hong Kong

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference70 articles.

1. Adult acute leukemia;Cornell;Dis Mon,2012

2. The natural history of chronic myelogenous leukemia in the interferon era;Giralt;Semin Hematol,1995

3. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia;Figueroa;Cancer Cell,2010

4. Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics;Speedy;Nat Commun,2019

5. Epigenetic reprogramming and emerging epigenetic therapies in CML;Bugler;Front Cell Dev Biol,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA sequestration in P-bodies sustains myeloid leukaemia;Nature Cell Biology;2024-08-21

2. To Erase or Not to Erase: Non-Canonical Catalytic Functions and Non-Catalytic Functions of Members of Histone Lysine Demethylase Families;International Journal of Molecular Sciences;2024-06-24

3. Inferring the Functional Effect of Gene-body H3K79me2 Signals in Normal Samples on Gene Expression Changes: A Potential Susceptibility Marker in Chronic Myelogenous Leukemia;Current Bioinformatics;2023-11

4. Noncoding rules of survival: epigenetic regulation of normal and malignant hematopoiesis;Frontiers in Molecular Biosciences;2023-10-31

5. Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies;Signal Transduction and Targeted Therapy;2023-02-17